特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
945481

血小板・血漿市場 - 業界分析レポート:コンポーネント・アプリケーション・流通チャネル・地域展望・成長可能性・価格動向・競合市場シェア & 予測 (2020-2026年)

Platelet and Plasma Market Size By Component, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
血小板・血漿市場 - 業界分析レポート:コンポーネント・アプリケーション・流通チャネル・地域展望・成長可能性・価格動向・競合市場シェア & 予測 (2020-2026年)
出版日: 2020年06月22日
発行: Global Market Insights Inc.
ページ情報: 英文 110 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血小板・血漿市場は、世界中で慢性疾患の発生が増加しているため、今後数年間でかなりの成長を示すと見込まれています。コンポーネントセグメントにおいて、血漿セグメントは、自己免疫疾患、血友病、遺伝性血管性浮腫およびその他の感染症などのまれな慢性疾患における血漿の使用の増加により、予測期間を通じて約2%のCAGRを示すと見込まれています。アプリケーションセグメントにおいて、周術期疾患は、主要な侵襲的手術では大量の失血を伴うことにより、患者の血小板を輸血で補う必要があるため、2019年に約15%の市場シェアを構成しました。流通チャネルセグメントでは、外来手術センターは、手ごろな料金で質の良い治療を受けられることから、人々の関心が高まっており、予測期間中は約2.5%のCAGRを示す可能性があります。地域別では、ラテンアメリカ地域が血友病、自己免疫障害、その他の感染症の発生率が高まっているため、2019年の市場規模は4億6,000万米ドルを上回りました。

当レポートでは、血小板・血漿の世界市場について調査分析し、市場の概要、コンポーネント・アプリケーション・流通チャネル・地域別の市場動向、市場規模の推移と予測、市場促進要因および阻害要因の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査手法

  • 調査手法
  • 市場定義
  • 予測パラメータ
  • データソース

第2章 エグゼクティブサマリー

  • 血小板・血漿市場の全方位的概要
    • ビジネス動向
    • コンポーネント動向
    • アプリケーション動向
    • 流通チャネル動向
    • 地域動向

第3章 血小板・血漿業界の考察

  • 産業セグメンテーション
  • 業界情勢
  • 産業エコシステム
    • バリューチェーン分析
    • 流通チャネル分析
  • 業界への影響要因
    • 成長要因
    • 業界の潜在的リスクと課題
  • 成長可能性分析
    • コンポーネント別
    • アプリケーション別
    • 流通チャネル別
  • COVID-19影響分析
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 血小板・血漿市場:コンポーネント別

  • 主要セグメントの動向
  • 血小板
    • 市場規模:地域別 (金額ベース)
  • 血漿

第5章 血小板・血漿市場:アプリケーション別

  • 主要セグメントの動向
  • 血友病
    • 市場規模:地域別 (金額ベース)
  • 血小板減少症
  • 周術期症状
  • 血小板機能障害
  • その他の血小板アプリケーション
  • 凝固因子欠乏症
  • 血栓性血小板減少性紫斑病
  • 出血
  • 肝疾患
  • その他の血漿アプリケーション

第6章 血小板・血漿市場:流通チャネル別

  • 主要セグメントの動向
  • 病院
    • 市場規模:地域別 (金額ベース)
  • 外来手術センター
  • その他

第7章 血小板・血漿市場:地域別

  • 市場シェア:地域別
  • 北米
    • 市場規模:国別 (金額ベース)
    • 市場規模:コンポーネント別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:流通チャネル別(金額ベース)
    • 米国
    • カナダ
  • 欧州
    • 市場規模:国別 (金額ベース)
    • 市場規模:コンポーネント別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:流通チャネル別(金額ベース)
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場規模:国別 (金額ベース)
    • 市場規模:コンポーネント別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:流通チャネル別(金額ベース)
    • 日本
    • 中国
    • インド
  • ラテンアメリカ
    • 市場規模:国別 (金額ベース)
    • 市場規模:コンポーネント別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:流通チャネル別(金額ベース)
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 市場規模:国別 (金額ベース)
    • 市場規模:コンポーネント別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:流通チャネル別(金額ベース)
    • 南アフリカ
    • サウジアラビア

第8章 企業プロファイル

  • Strategy Dashboard
  • America's Blood Centers
  • American Red Cross
  • American Association of Blood Banks
  • Blood Centers of America
  • European Blood Alliance
  • Indian Red Cross
  • Italian Red Cross
  • 日本赤十字社
  • South African Red Cross Society
  • OneBlood
図表

Data Tables

  • TABLE 1 Platelet and plasma industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • TABLE 3 Global platelet and plasma market, by component, 2015 - 2026 (USD Million)
  • TABLE 4 Global platelet and plasma market, by application, 2015 - 2026 (USD Million)
  • TABLE 5 Global platelet and plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 6 Industry impact forces
  • TABLE 7 Platelets market, by region, 2015 - 2026 (USD Million)
  • TABLE 8 Plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 9 Hemophilia market, by region, 2015 - 2026 (USD Million)
  • TABLE 10 Thrombocytopenia market, by region, 2015 - 2026 (USD Million)
  • TABLE 11 Perioperative indications market, by region, 2015 - 2026 (USD Million)
  • TABLE 12 Platelet function disorders market, by region, 2015 - 2026 (USD Million)
  • TABLE 13 Other platelet applications market, by region, 2015 - 2026 (USD Million)
  • TABLE 14 Coagulation factor deficiencies market, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Thrombotic thrombocytopenic purpura market, by region, 2015 - 2026 (USD Million)
  • TABLE 16 Hemorrhage market, by region, 2015 - 2026 (USD Million)
  • TABLE 17 Liver disease market, by region, 2015 - 2026 (USD Million)
  • TABLE 18 Other plasma applications market by region, 2015 - 2026 (USD Million)
  • TABLE 19 Hospitals market by region, 2015 - 2026 (USD Million)
  • TABLE 20 Ambulatory surgical centers market by region, 2015 - 2026 (USD Million)
  • TABLE 21 Others market by region, 2015 - 2026 (USD Million)
  • TABLE 22 North America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 23 North America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 24 North America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 25 North America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 26 U.S. platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 27 U.S. platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 28 U.S. platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 29 Canada platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 30 Canada platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 31 Canada platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 32 Europe platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 33 Europe platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 34 Europe platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 35 Europe platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 36 Germany platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 37 Germany platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 38 Germany platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 39 UK platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 40 UK platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 41 UK platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 42 France platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 43 France platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 44 France platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 45 Italy platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 46 Italy platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 47 Italy platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 48 Spain platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 49 Spain platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 50 Spain platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 51 Asia Pacific platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 52 Asia Pacific platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 53 Asia Pacific platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Asia Pacific platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 55 Japan platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 56 Japan platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 57 Japan platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 58 China platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 59 China platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 60 China platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 61 India platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 62 India platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 63 India platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 64 Latin America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 65 Latin America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 66 Latin America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Latin America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 68 Brazil platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 69 Brazil platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 70 Brazil platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 71 Mexico platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 72 Mexico platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 73 Mexico platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 74 MEA platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 75 MEA platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 76 MEA platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 77 MEA platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 78 South Africa platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 79 South Africa platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 80 South Africa platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 81 Saudi Arabia platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 82 Saudi Arabia platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 83 Saudi Arabia platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • FIG. 3 Growth potential analysis, by component
  • FIG. 4 Growth potential analysis, by application
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 PESTEL Analysis
  • FIG. 8 Strategy dashboard
目次
Product Code: 2737

Title:
Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026.

The platelet and plasma market is set to record considerable growth in coming years due to the increasing occurrence of chronic diseases across the globe. In modern day medical therapies, patients can receive either a pint of complete blood or just specific components present within the blood that are essential to treat particular conditions. This treatment approach, known as a blood component treatment, enables several patients to receive more benefit from a single pint of the donated whole blood.

Blood contains several different components, which includes platelets, red blood cells, plasma, and white blood cells. Today, the demand for platelet and plasma donations is increasing tremendously as they can address particular conditions more effectively.

In platelet donations, platelets are collected from the blood of a donor and then the remaining blood and the components in it are returned back to the donor. These platelets allows blood to clot, and are commonly given to people suffering from leukemia, to people undergoing chemotherapy, and to babies suffering from severe infections.

Similarly, the liquid part of the blood, known as plasma, is collected from the donor with the remaining components of the blood being returned back to the donor. Plasma also effectively helps blood to form clots, and is commonly used to treat people suffering from liver conditions, severe bacterial infections within the blood and burns.

The overall platelet and plasma market is divided into segments based on component, application, distribution channel, and regional landscape.

By component, the market is divided into platelets, and plasma. Among these, the plasma segment is expected to record around 2% CAGR through the forecast timeframe due to the rising usage of plasma in rare chronic diseases such as autoimmune diseases, hemophilia, hereditary angioedema and other infectious diseases.

In terms of application, the market is divided into thrombocytopenia, hemophilia, platelet function disorders, perioperative Indications, coagulation factor deficiencies, other platelet applications, hemorrhage, thrombotic thrombocytopenic purpura, other plasma applications, and liver disease.

Among these, the perioperative indications held around 15% market share in 2019 due to the significant blood loss during major invasive surgeries that is compensated by transfusing platelets in the patients.

Based on distribution channel, the industry is classified into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers is likely to witness around 2.5% CAGR over the projected timeframe, due to the increasing preference of people towards ambulatory surgeries owing to the quality treatment at affordable prices.

Regionally, the LATAM market held a market value of over $460 million in 2019, owing to the growing incidence of hemophilia, autoimmune disorder, as well as other infectious diseases.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data Sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Platelet and plasma industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Component trends
    • 2.1.3. Application trends
    • 2.1.4. Distribution channel trends
    • 2.1.5. Regional trends

Chapter 3. Platelet and Plasma Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry ecosystem
    • 3.3.1. Value chain analysis
    • 3.3.2. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Higher number of blood transfusions in Europe
      • 3.4.1.2. Recent advances in therapeutic protein drug development
      • 3.4.1.3. Increasing prevalence of liver diseases in elderly population
      • 3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe
      • 3.4.1.5. Fair reimbursement in developed countries
    • 3.4.2. Industry pitfalls & challenges
      • 3.4.2.1. Stringent regulatory policies
      • 3.4.2.2. Affordability issue in APAC and Latin America due to high costs
  • 3.5. Growth potential analysis
    • 3.5.1. By component
    • 3.5.2. By application
    • 3.5.3. By distribution channel
  • 3.6. COVID-19 impact analysis
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Platelet and Plasma Market, By Component

  • 4.1. Key segment trends
  • 4.2. Platelets
    • 4.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.3. Plasma
    • 4.3.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Platelet and plasma Market, By Application

  • 5.1. Key segment trends
  • 5.2. Hemophilia
    • 5.2.1. Market size, by region, 2015-2026 (USD Million)
  • 5.3. Thrombocytopenia
    • 5.3.1. Market size, by region, 2015-2026 (USD Million)
  • 5.4. Perioperative indications
    • 5.4.1. Market size, by region, 2015-2026 (USD Million)
  • 5.5. Platelet function disorders
    • 5.5.1. Market size, by region, 2015-2026 (USD Million)
  • 5.6. Other platelet applications
    • 5.6.1. Market size, by region, 2015-2026 (USD Million)
  • 5.7. Coagulation factor deficiencies
    • 5.7.1. Market size, by region, 2015-2026 (USD Million)
  • 5.8. Thrombotic thrombocytopenic purpura
    • 5.8.1. Market size, by region, 2015-2026 (USD Million)
  • 5.9. Hemorrhage
    • 5.9.1. Market size, by region, 2015-2026 (USD Million)
  • 5.10. Liver disease
    • 5.10.1. Market size, by region, 2015-2026 (USD Million)
  • 5.11. Other plasma applications
    • 5.11.1. Market size, by region, 2015-2026 (USD Million)

Chapter 6. Platelet and Plasma Market, By Distribution Channel

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 7. Platelet and plasma Market, By Region

  • 7.1. Platelet and plasma market share, by region, 2017 & 2024
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.2.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.2.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.2.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.3.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.3.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.3.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.8.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.8.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.9.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.9.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.4.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.4.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.4.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.5.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.5.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.5.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.6.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.6.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.6.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Strategy Dashboard
  • 8.2. America's Blood Centers
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. American Red Cross
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. American Association of Blood Banks
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Blood Centers of America
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. European Blood Alliance
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Indian Red Cross
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Italian Red Cross
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Japanese Red Cross
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. South African Red Cross Society
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. OneBlood
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.